Introduction
============

The process of TCR generation, that is based on random rearrangements, as well as the promiscuity of the resulting receptor expressed by mature T cells requires central and peripheral mechanisms of tolerance induction ([@bib1]). CD25^+^ T regulatory (Treg) cells play a central role in the maintenance of peripheral tolerance as the depletion of these cells in a murine adoptive transfer model leads to various autoimmune diseases ([@bib2], [@bib3]). These CD4^+^ T cells express CD25 but do not or only marginally proliferate after polyclonal or antigen-specific activation. However, although they seem to be immunologically inert, activated CD25^+^ Treg cells strongly suppress the proliferation of coactivated conventional CD4^+^CD25^−^ T cells in vitro ([@bib4], [@bib5]). We and others characterized a human equivalent of murine CD25^+^ Treg cells that has comparable properties and can be isolated from human peripheral blood ([@bib6]--[@bib8]). The suppressive capacity of these human CD25^+^ Treg cells depends on direct cell--cell contact but the mechanism of suppression is largely unknown. Several studies implied that signaling through CTLA-4 might be responsible for the inhibitory potency of CD25^+^ Treg cells, whereas others could not confirm this finding ([@bib2]). Studies using a murine IBD model suggest that TGF-β and IL-10 are potent mediators of suppression ([@bib9], [@bib10]). However, neither anti--IL-10 nor anti--TGF-β antibodies could abrogate the suppressive capacity of human CD25^+^ Treg cells in vitro ([@bib6]). On the other hand, it was shown that blocking anti--TGF-β antibodies abrogated suppressor activity in vivo ([@bib9], [@bib11], [@bib12]). Hence, there are a lot of conflicting and contradictory findings regarding the suppressive mechanisms of CD25^+^ Treg cells. Herein we demonstrate that coculture of human CD25^+^ Treg cells with CD25^−^CD4^+^ T cells results in the development of an additional CD4^+^ T suppressor cell population. These induced CD4^+^ Treg cells emerge from the CD25^−^CD4^+^ T cell population and suppress the proliferation of freshly isolated conventional CD4^+^ T cells. This process is partially mediated by soluble TGF-β.

Materials and Methods
=====================

Culture Medium.
---------------

X-VIVO-15 supplemented with 1% autologous plasma was used for culture of dendritic cells (DCs) and without plasma for culture of T cells (BioWhittaker).

Cytokines.
----------

All cytokines used in this study were recombinant human proteins. Final concentrations: 800 U/ml GM-CSF (Leukomax), IL-4, 1,000 U/ml IL-6 (Strathmann Biotech GmbH), IL-1β, 10 ng/ml TNF-α (Strathmann), and PGE~2~ (Minprostin; Pharmacia-Upjohn) 1 μg/ml. The DCs were generated from buffy coats of healthy volunteers as described previously ([@bib13]). For preactivation of T cells: IL-2 (Proleukin; Chiron) 10 U/ml.

Antibodies.
-----------

These mAbs were used for the staining of MACS^®^-sorted T cells: FITC- or PE-conjugated CD3, CD4, CD25, CTLA-4, anti--HLA-A,B,C, and FITC- and PE-conjugated mouse IgG (Beckman Coulter and Immunotech). These mAbs were used for the staining of membrane-bound TGF-β: LAP (biotinylated mAb, R&D Systems, used according to the manufacturer\'s instructions) detected by streptavidin-Cy5 (Dianova). The anti--TGF-β (R&D Systems, used according to the manufacturer\'s instructions) and anti--IL-10 mAb (JES-19F1.1.1; American Type Culture Collection (ATCC), blocking capacity tested in proliferation assays using IL-10 receptor transfected Baf3 cells) were used for blocking experiments ([@bib14]). For sorting of preactivated HLA-A2--positive conventional CD4^+^ T cells, purified anti--HLA-A2--positive-specific mAb (BB7.2; ATCC) and anti--mouse IgG microbeads (Miltenyi Biotec) were used. Labeled T cells were analyzed by flow cytometry (FACScalibur™ and CELLQuest™; Becton Dickinson). Necrosis versus apoptosis were determined by propidium iodide and annexin-V staining according to the manufacturer\'s instructions (BD PharMingen).

Isolation and Stimulation of T Cell Populations.
------------------------------------------------

Conventional CD4^+^ Th cells and CD4^+^CD25^+^ regulatory T cells were isolated from buffy coats of healthy volunteers as described previously ([@bib6]). Briefly, CD4-MACS^®^-Multisort-Beads (Miltenyi Biotec) were used for isolation of CD4^+^ T cells. After detaching, cells were washed and CD4^+^CD25^+^ T cells were positively selected according to the instructions of the manufacturer using CD25 microbeads. For some experiments, CD4^+^CD25^+^ T cells and conventional CD4^+^ T cells were preactivated with 0.5 μg/ml anti-CD3 mAb at 37°C for 20 h in the presence of 10 U/ml IL-2. Aliquots of the cultures were used for proliferation assays performed in X-VIVO-15 and in the presence of different numbers of allogeneic DCs or anti-CD3/CD28 stimulation in 96-well plates. T cell proliferation was measured after 3--4 d of incubation and an additional 16-h pulse with ^3^\[H\]Tdr (37 kBq/well) using a liquid scintillation counter.

Isolation of Precultured CD4^+^ T Cells.
----------------------------------------

10^6^ freshly isolated HLA-A2-negative CD4^+^ T cells and 10^6^ HLA-A2-positive CD25^+^ Treg from a different donor were coactivated with anti-CD3 (1 μg/ml) and anti-CD28 (2 μg/ml) mAb. After 6 d of coculture the CD25^+^ Treg cells were stained with a HLA-A2-specific mAb and depleted from the anergized CD4^+^ T cells using anti--mouse IgG microbeads (purity \>95%). The anergized CD4^+^ T cells were restimulated with anti-CD3/CD28 mAb as described previously. 24--72 h after restimulation aliquots were used for detection of TGF-β by ELISA (DRG-Instruments, detection limit of biologically active TGF-β: 4.7 pg/ml).

Transwell Experiments.
----------------------

Transwell experiments were done in 24-well plates as described previously ([@bib14]). Briefly, 10^6^ CD4^+^ conventional T cells or CD4^+^CD25^+^ T cells were stimulated with anti-CD3 (1 μg/ml) and anti-CD28 (2 μg/ml) in 1.5 ml. Additionally, 10^6^ CD4^+^CD25^+^ T cells or precultured CD4^+^ T cells (Thsup) were either directly added to cultures of activated conventional CD4^+^ T cells or were placed in transwell chambers (Millicell, 0.4 μm; Millipore) in the same well. After 3 d of culture, activated T cells (200 μl per well) were transferred to 96-well plates in triplicates. Proliferation was measured after an additional 16-h pulse with ^3^\[H\]Tdr using a liquid scintillation counter.

Fixation of Freshly Isolated and Preactivated T Cells.
------------------------------------------------------

For some experiments, conventional CD4^+^ T helper cells and CD25^+^ Treg were fixed with 1% paraformaldehyde for 10 min in PBS, either directly after isolation or 20 h after preactivation with 0.5 μg/ml anti-CD3 mAb and 10 U/ml IL-2. Additionally, CD25^+^ Treg were preactivated in the presence of 10 μg/ml cycloheximide or 1 μg/ml monensin. These concentrations of cycloheximide and monensin showed no toxic effects but blocked the upregulation of CTLA-4 on CD25^+^ Treg and CD25 on conventional CD4^+^ T cells during preactivation (unpublished data). Fixed cells were washed intensively with RPMI 1640 plus 10% FCS and used for coculture with freshly isolated CD4^+^ T cells in proliferation assays.

Results and Discussion
======================

CD25^−^ conventional CD4^+^ T cells and CD25^+^ Treg cells were isolated from buffy coats of healthy volunteers as described previously ([@bib6]). Freshly isolated, CD25^+^ Treg cells showed a fourfold increased expression of membrane-bound TGF-β as compared with conventional CD4^+^ Th cells ([Fig. 1](#fig1){ref-type="fig"} A). However, polyclonal activation using anti-CD3 in combination with anti-CD28 antibodies resulted in an upregulated surface expression of TGF-β on conventional CD4^+^ T cells, whereas TGF-β on CD25^+^ Treg cells was downregulated. Both populations, CD25^+^ Treg cells and conventional CD4^+^ Th cells, either resting or activated, showed no significant production of biologically active soluble TGF-β (see [Fig. 4](#fig4){ref-type="fig"} C).

###### 

The suppressive activity of human CD25^+^ Treg cells is independent from membrane-bound TGF-β. CD4^+^ and CD4^+^CD25^+^ T cells were isolated from buffy coats of healthy volunteers by positive selection using paramagnetic beads. (A) Surface expression of TGF-β by freshly isolated CD4^+^ T cells and CD25^+^ Treg cells in comparison to the same T cell populations preactivated for 48 h with anti-CD3 (OKT3, 1 μg/ml) and anti-CD28 mAb (CD28.2, 2 μg/ml). The figure shows the expression of TGF-β (LAP-biotinylated) detected by streptavidin-Cy5 and CD4 (RPAT4-FITC). (B) CD4^+^ T cells (10^5^ cells per well) or CD25^+^ Treg cells (10^5^ cells per well), alone or in coculture (1:1), were stimulated with allogeneic mature DC (10^4^ cells per well) or by anti-CD3 (1 μg/ml) plus anti-CD28 mAb (2 μg/ml). Neutralizing anti-TGF-β mAb (10 μg/ml) was added to the cocultured cells as indicated. ^3^\[H\]Tdr was added after 3 (polyclonal stimulation) or 4 d (allogeneic MLR) of culture for the final 16 h.
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###### 

The suppressive activity of CD251 Treg-induced CD4^+^ Th cells is partially mediated by soluble TGF-β. (A) 10^6^ Freshly isolated CD4^+^ T cells were activated alone or in coculture with 10^6^ CD25^+^ Treg cells or 10^6^ Th~sup~ cells by anti-CD3 (1 μg/ml) and anti-CD28 mAb (2 μg/ml). Transwell chambers were used to prevent the direct cell contact between the T cell populations, neutralizing mAb against TGF-β were used at 10 μg/ml. After 3 d, aliquots from all approaches were transferred to 96-well microplates and ^3^\[H\]Tdr was added for the final 16 h. (B) Freshly isolated CD4^+^ T cells were activated alone or in coculture with freshly isolated CD25^+^ Treg cells. In addition, such CD4^+^ T cells were coactivated with CD25^+^ Treg cells or Th~sup~ cells that had been fixed after preactivation with 0.5 μg/ml anti-CD3 mAb plus 10 U/ml IL-2 for 20 h (1:1). ^3^\[H\]Tdr (1 μCi per well) was added after 3 d of culture for the final 16 h. (C) Freshly isolated CD4^+^ T cells and CD25^+^ Treg cells or a mixture of both were activated with anti-CD3 (1 μg/ml) and anti-CD28 mAb (2 μg/ml) for 3 d. Th~sup~ cells were also activated under the same conditions for 20 and 96 h, respectively. The content of biologically active TGF-β of the resulting supernatants was assessed by a TGF-β--specific ELISA.
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To analyze the potential inhibitory effect of membrane-bound TGF-β on the surface of freshly isolated human CD25^+^ Treg cells, as postulated for murine CD25^+^ Treg cells ([@bib15]), we stimulated freshly isolated CD4^+^ Th cells in coculture with human CD25^+^ Treg cells and in the presence or absence of blocking antibodies against TGF-β. As shown in [Fig. 1](#fig1){ref-type="fig"} B, the presence of anti--TGF-β antibodies could not reverse the cell contact--dependent inhibitory effect of the CD25^+^ Treg population on the proliferation of CD4^+^ Th cells, neither upon allogeneic nor polyclonal stimulation of Th cells. Thus, these data indicate that membrane-bound TGF-β is not responsible for the suppressive effects of freshly isolated human CD25^+^ Treg cells. In addition, the fact that highly proliferative CD4^+^ Th cells express the same amounts of TGF-β as highly suppressive CD25^+^ Treg cells ([Fig. 1](#fig1){ref-type="fig"} A) also strongly argues against the assumption that membrane-bound TGF-β is responsible for the suppressive capacity of human CD25^+^ Treg cells.

To analyze the suppressive mechanism in more detail, we stimulated CD4^+^ T cells in the presence of fixed CD25^+^ Treg cells. In coculture experiments, freshly isolated human CD25^+^ Treg cells inhibited the proliferation and cytokine production of coactivated conventional CD4^+^ T cells in a dose-dependent manner. If CD25^+^ Treg cells were fixed directly after isolation, no suppressive activity could be detected ([Fig. 2](#fig2){ref-type="fig"} A). However, if CD25^+^ Treg cells were preactivated overnight with anti-CD3 antibodies (0.5 μg/ml) and 10 U/ml IL-2 before fixation, they showed a comparable suppressive capacity for CD4^+^ T cells as unfixed CD25^+^ Treg cells. In contrast, Treg-depleted and activated conventional CD4^+^ T helper cells did not exert any suppressive activity, although such cells express comparable amounts of TGF-β ([Fig. 1](#fig1){ref-type="fig"} A). These data suggest that the inhibitory function of human CD25^+^ Treg cells is activation dependent. Additional experiments revealed that the induction of suppressor activity requires protein synthesis as it can be inhibited by the presence of cycloheximide or monensin ([Fig. 2](#fig2){ref-type="fig"} B). However, once activated, the suppressive activity of human CD25^+^ Treg cells is fixation-resistant ([Fig. 2](#fig2){ref-type="fig"} A). These data also strongly corroborate our findings that the inhibitory function of human CD25^+^ Treg cells is independent of soluble mediators ([@bib6]). Furthermore, the activation of suppressor function of human CD25^+^ Treg is also independent of costimulation, since the addition of mature DCs or soluble anti-CD28 antibodies during overnight preactivation with anti-CD3 antibodies did not alter/enhance the functional activities of human CD25^+^ Treg cells (unpublished data).

###### 

The suppressive activity of activated CD25^+^ Treg cells is fixation-resistant but the activation is sensitive to treatment with monensin or cycloheximide. (A) Freshly isolated CD4^+^ T cells (10^5^ cells per well) and CD25^+^ Treg cells (10^5^ cells per well) or a combination of both (1:1) were activated with anti-CD3 (1 μg/ml) and anti-CD28 mAb (2 μg/ml). In addition, CD4^+^ T cells were coactivated with CD25^+^ Treg cells or conventional CD4^+^ T cells that were immediately fixed after isolation (1% paraformaldehyde, 10 min) or were fixed after preactivation with 0.5 μg anti-CD3 mAb plus 10 U/ml IL-2 for 20 h (black bars). (B) CD4^+^ T cells were coactivated either with preactivated and fixed CD25^+^ Treg cells or with CD25^+^ Treg cells treated with monensin (1 μg/ml) or cycloheximide (10 μg/ml) during preactivation before fixation. ^3^\[H\]Tdr was added after 3 d of culture for the final 16 h.
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We and others could not detect any influence of TGF-β on the cell contact--mediated inhibitory function of CD25^+^ Treg cells in vitro ([@bib2], [@bib6]), whereas several groups demonstrated that neutralizing antibodies against TGF-β abrogated the suppressive function of murine CD25^+^ Treg cells in vivo ([@bib9], [@bib15]). One possible explanation for this discrepancy could be that CD25^+^ Treg cells exert an additional suppressive mechanism that is presumably also involved in the phenomena of bystander suppression or infectious tolerance ([@bib10], [@bib16]) but is not directly mediated by the CD25^+^ Treg cells themselves. Consequently, we analyzed the functional properties of the anergized conventional CD4^+^ Th cells after coculture with human CD25^+^ Treg cells. To distinguish both T cell populations, HLA-mismatched CD25^+^ Treg cells were used and depleted of the anergized CD4^+^ T cells after coculture with the aid of HLA-specific mAbs as illustrated in [Fig. 3](#fig3){ref-type="fig"} A. Coculture of HLA-mismatched conventional CD4^+^ T cells served as a control. As shown in [Fig. 3](#fig3){ref-type="fig"} B, the purified CD4^+^ T cells, anergized by CD25^+^ Treg cells, revealed a strong suppressive activity for conventional CD4^+^ Th cells that was comparable to the inhibitory capacity of CD25^+^ Treg cells. Thus, human CD25^+^ Treg cells, in a cell contact--dependent fashion, suppress the proliferation of conventional CD4^+^ T cells and simultaneously induce suppressive activity in these CD4^+^ Th cells ([Fig. 3](#fig3){ref-type="fig"} B). In contrast, conventional CD4^+^ T cells preactivated in the presence of HLA-mismatched conventional CD4^+^ T cells showed no suppressive activity for freshly isolated Th cells ([Fig. 3](#fig3){ref-type="fig"} B, lowest bar).

###### 

CD25^+^ Treg cells convey a suppressive activity to conventional CD4^+^ Th cells. (A) Cocultured HLA-A2-positive CD25^+^ Treg cells (10^6^/ml) and HLA-mismatched CD4^+^ T cells (10^6^/ml, HLA-A2-negative) were primarily activated by anti-CD3 (1 μg/ml) and anti-CD28 mAb (2 μg/ml). As a control HLA-A2-negative CD4^+^ T cells were also coactivated with HLA-A2-positive CD4^+^ T cells. After 6 d of culture the HLA-A2-positive CD25^+^ Treg cells and HLA-A2-positive CD4^+^ T cells were depleted from HLA-A2-negative CD4^+^ T cells using a HLA-specific mAb (BB7.2) and paramagnetic microbeads (purity of precultured CD4^+^ T cells \>95%). (B) The remaining precultured CD4^+^ T cells (10^5^ cells per well) were γ-irradiated (3,000 rad) and secondarily stimulated with freshly isolated CD4^+^ responder T cells (10^5^ cells per well, 1:1) using anti-CD3 and anti-CD28 mAb. In addition, freshly isolated CD25^+^ Treg cells were used as a control population. ^3^\[H\]Tdr was added after 3 d of culture for the final 16 h.
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To elucidate the mechanism of this conveyed suppressive activity, we analyzed the properties of the anergized CD4^+^ T cells (subsequently termed Th~sup~) in comparison to the original CD25^+^ Treg population in transwell stimulations. The semipermeable transwell membrane prevents direct cell--cell contact between the responsive Th cell population and the suppressor T cells. As shown recently, the physical separation by the transwell membrane abrogated the cell contact--dependent suppression of CD4^+^ Th cells by CD25^+^ Treg cells ([@bib6]). In contrast, the conveyed suppressor activity of Th~sup~ cells could not be abrogated by the semipermeable membrane ([Fig. 4](#fig4){ref-type="fig"} A). However, fixation of such Th~sup~ cells completely abrogated their suppressor function while it could not inhibit the suppressive properties of activated CD25^+^ Treg cells ([Fig. 4](#fig4){ref-type="fig"} B). These data strongly support our primary finding that the induced secondary suppressor activity of Th~sup~ cells is cell contact independent. In addition, these results were further confirmed by the fact, that the suppressive activity of Th~sup~ cells could be partially abrogated upon the addition of neutralizing anti--TGF-β antibodies ([Fig. 4](#fig4){ref-type="fig"} A), whereas neutralizing anti--IL-10 antibodies showed no effect (data not shown). These data strongly suggest that the suppressive activity of Th~sup~ cells is mediated partially by biologically active TGF-β. Therefore, the production of TGF-β was assessed by using an ELISA that specifically detects biologically active material. As shown in [Fig. 4](#fig4){ref-type="fig"} C, Th~sup~ cells produce biologically active TGF-β immediately after polyclonal stimulation. In contrast, neither conventional CD4^+^ Th cells nor CD25^+^ Treg cells, alone or in coculture, produced detectable amounts of TGF-β. This finding again strongly supports our thesis that resident human CD25^+^ Treg cells convey a suppressor function to conventional CD4^+^ Th cells that is completely cell contact independent and mediated mainly by TGF-β.

In summary, our findings help to explain several conflicting and contradictory results published previously. In accordance with published data on the properties of resident murine and human CD25^+^ Treg in vitro ([@bib2], [@bib6], [@bib8]), we show that the primary functional activity of CD25^+^ Treg is strictly activation- and cell contact--dependent and independent of soluble mediators. Moreover, our data clearly indicate that classical human CD25^+^ Treg cells can, in a cell contact--dependent manner, direct the differentiation of conventional CD4^+^ Th cells toward an additional population of regulatory T cells (Th~sup~). Both regulatory T cell populations can inhibit Th cell proliferation through distinct suppressor mechanisms (cell contact--dependent versus soluble mediators). Thus, these results imply that human CD25^+^ Treg cells can amplify their suppressive capacity through the recruitment of an additional population of suppressor T cells that exert a distinct but complementary suppressor mechanism. Data from murine in vivo studies suggest that the suppressive properties of CD25^+^ Treg cells are mediated via soluble mediators such as TGF-β ([@bib2]). In contrast, in vitro studies clearly revealed that murine and human CD25^+^ Treg cells inhibit T cell proliferation via cell contact and independent from soluble factors ([@bib6], [@bib8]). These apparently discordant results could be reconciled by the assumption that in vitro a local cell contact--dependent mechanism is sufficient to inhibit the proliferation of the responding T cell population. However, in vivo, e.g., in the murine model of IBD ([@bib9]), additional soluble suppressive mediators such as TGF-β, derived from anergized CD4^+^ Th cells, are important for the systemic control of autoreactive T effector cells ([Fig. 5](#fig5){ref-type="fig"}) . Finally, the regulation of immune responses that includes bystander suppression and infectious tolerance ([@bib10], [@bib16]) obviously requires a transfer of tolerizing potencies from resident or induced CD25^+^ Treg cells to another T cell population with a different antigen specificity. Hence, we would like to speculate that the spreading of suppression from human CD25^+^ Treg cells to conventional CD4^+^ Th cells is one of the fundamental mechanisms that is involved in the induction or maintenance of peripheral tolerance.

![Model of T effector cell regulation. We propose the following model of immunoregulation by CD25^+^ Treg in vivo: resident or induced CD25^+^ Treg suppress the activation of conventional Th cells. This is a cell contact--dependent local inhibitory effect. The induced secondary T suppressor cells (Th~sup~) produce inhibitory mediators such as biologically active TGF-β which itself inhibits the activation of T effector cells. This secondary systemic suppressive effect is cell contact independent.](20020394f5){#fig5}
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